{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T21:07:43Z","timestamp":1761253663569},"reference-count":49,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4,28]]},"DOI":"10.7759\/cureus.38239","type":"journal-article","created":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T11:23:46Z","timestamp":1682681026000},"source":"Crossref","is-referenced-by-count":2,"title":["Japanese Herbal Medicine (Kampo) as a Possible Treatment for Ischemia With Non-obstructive Coronary Artery Disease"],"prefix":"10.7759","author":[{"given":"Hiroki","family":"Teragawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chikage","family":"Oshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Uchimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.08.1056","article-title":"Coronary functional abnormalities in patients with angina and nonobstructive coronary artery disease","volume":"74","author":"Suda A","year":"2019","unstructured":"Suda A, Takahashi J, Hao K, et al.. Coronary functional abnormalities in patients with angina and nonobstructive coronary artery disease. J Am Coll Cardiol. 2019, 74:2350-60. 10.1016\/j.jacc.2019.08.1056","journal-title":"J Am Coll Cardiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab775","article-title":"Coronary flow reserve and cardiovascular outcomes: a systematic review and meta-analysis","volume":"43","author":"Kelshiker MA","year":"2022","unstructured":"Kelshiker MA, Seligman H, Howard JP, et al.. Coronary flow reserve and cardiovascular outcomes: a systematic review and meta-analysis. Eur Heart J. 2022, 43:1582-93. 10.1093\/eurheartj\/ehab775","journal-title":"Eur Heart J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa503","article-title":"An EAPCI expert consensus document on ischaemia with non-obstructive coronary arteries in collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & microcirculation endorsed by coronary vasomotor disorders international study group","volume":"41","author":"Kunadian V","year":"2020","unstructured":"Kunadian V, Chieffo A, Camici PG, et al.. An EAPCI expert consensus document on ischaemia with non-obstructive coronary arteries in collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & microcirculation endorsed by coronary vasomotor disorders international study group. Eur Heart J. 2020, 41:3504-20. 10.1093\/eurheartj\/ehaa503","journal-title":"Eur Heart J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jjcc.2008.01.001","article-title":"Coronary artery spasm--clinical features, diagnosis, pathogenesis, and treatment","volume":"51","author":"Yasue H","year":"2008","unstructured":"Yasue H, Nakagawa H, Itoh T, Harada E, Mizuno Y. Coronary artery spasm--clinical features, diagnosis, pathogenesis, and treatment. J Cardiol. 2008, 51:2-17. 10.1016\/j.jjcc.2008.01.001","journal-title":"J Cardiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.119.008126","article-title":"Ischemia and no obstructive coronary artery disease: prevalence and correlates of coronary vasomotion disorders","volume":"12","author":"Ford TJ","year":"2019","unstructured":"Ford TJ, Yii E, Sidik N, et al.. Ischemia and no obstructive coronary artery disease: prevalence and correlates of coronary vasomotion disorders. Circ Cardiovasc Interv. 2019, 12:e008126. 10.1161\/CIRCINTERVENTIONS.119.008126","journal-title":"Circ Cardiovasc Interv"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.09.006","article-title":"Stratified medical therapy using invasive coronary function testing in angina: the cormica trial","volume":"72","author":"Ford TJ","year":"2018","unstructured":"Ford TJ, Stanley B, Good R, et al.. Stratified medical therapy using invasive coronary function testing in angina: the cormica trial. J Am Coll Cardiol. 2018, 72:2841-55. 10.1016\/j.jacc.2018.09.006","journal-title":"J Am Coll Cardiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes","volume":"41","author":"Knuuti J","year":"2020","unstructured":"Knuuti J, Wijns W, Saraste A, et al.. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020, 41:407-77. 10.1093\/eurheartj\/ehz425","journal-title":"Eur Heart J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s00380-014-0591-7","article-title":"Safety and optimal protocol of provocation test for diagnosis of multivessel coronary spasm","volume":"31","author":"Sueda S","year":"2016","unstructured":"Sueda S, Miyoshi T, Sasaki Y, Sakaue T, Habara H, Kohno H. Safety and optimal protocol of provocation test for diagnosis of multivessel coronary spasm. Heart Vessels. 2016, 31:137-42. 10.1007\/s00380-014-0591-7","journal-title":"Heart Vessels"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2021.10.003","article-title":"Acetylcholine rechallenge: a first step toward tailored treatment in patients with coronary artery spasm","volume":"15","author":"Seitz A","year":"2022","unstructured":"Seitz A, Feenstra R, Konst RE, et al.. Acetylcholine rechallenge: a first step toward tailored treatment in patients with coronary artery spasm. JACC Cardiovasc Interv. 2022, 15:65-75. 10.1016\/j.jcin.2021.10.003","journal-title":"JACC Cardiovasc Interv"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.101.10.1102","article-title":"Major racial differences in coronary constrictor response between Japanese and Caucasians with recent myocardial infarction","volume":"101","author":"Pristipino C","year":"2000","unstructured":"Pristipino C, Beltrame JF, Finocchiaro ML, et al.. Major racial differences in coronary constrictor response between Japanese and Caucasians with recent myocardial infarction. Circulation. 2000, 101:1102-8. 10.1161\/01.cir.101.10.1102","journal-title":"Circulation"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.113.000227","article-title":"Coronary vasomotor response to intracoronary acetylcholine injection, clinical features, and long-term prognosis in 873 consecutive patients with coronary spasm: analysis of a single-center study over 20 years","volume":"2","author":"Sato K","year":"2013","unstructured":"Sato K, Kaikita K, Nakayama N, et al.. Coronary vasomotor response to intracoronary acetylcholine injection, clinical features, and long-term prognosis in 873 consecutive patients with coronary spasm: analysis of a single-center study over 20 years. J Am Heart Assoc. 2013, 2:e000227. 10.1161\/JAHA.113.000227","journal-title":"J Am Heart Assoc"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1253\/circj.cj-66-0098","article-title":"Guidelines for diagnosis and treatment of patients with vasospastic angina (Coronary Spastic Angina) (JCS 2013)","volume":"78","author":"JCS Joint Working Group","year":"2014","unstructured":"JCS Joint Working Group. Guidelines for diagnosis and treatment of patients with vasospastic angina (Coronary Spastic Angina) (JCS 2013). Circ J. 2014, 78:2779-801. 10.1253\/circj.cj-66-0098","journal-title":"Circ J"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s12928-020-00720-z","article-title":"Role of acetylcholine spasm provocation test as a pathophysiological assessment in nonobstructive coronary artery disease","volume":"36","author":"Suzuki S","year":"2021","unstructured":"Suzuki S, Kaikita K, Yamamoto E, Jinnouchi H, Tsujita K. Role of acetylcholine spasm provocation test as a pathophysiological assessment in nonobstructive coronary artery disease. Cardiovasc Interv Ther. 2021, 36:39-51. 10.1007\/s12928-020-00720-z","journal-title":"Cardiovasc Interv Ther"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2017.08.068","article-title":"International standardization of diagnostic criteria for microvascular angina","volume":"250","author":"Ong P","year":"2018","unstructured":"Ong P, Camici PG, Beltrame JF, et al.. International standardization of diagnostic criteria for microvascular angina. Int J Cardiol. 2018, 250:16-20. 10.1016\/j.ijcard.2017.08.068","journal-title":"Int J Cardiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11010130","article-title":"Coronary microvascular vasodilatory function: related clinical features and differences according to the different coronary arteries and types of coronary spasm","volume":"11","author":"Teragawa H","year":"2021","unstructured":"Teragawa H, Oshita C, Uchimura Y, Akazawa R, Orita Y. Coronary microvascular vasodilatory function: related clinical features and differences according to the different coronary arteries and types of coronary spasm. J Clin Med. 2021, 11:10.3390\/jcm11010130","journal-title":"J Clin Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.87.1.76","article-title":"Cigarette smoking is a major risk factor for coronary spasm","volume":"87","author":"Sugiishi M","year":"1993","unstructured":"Sugiishi M, Takatsu F. Cigarette smoking is a major risk factor for coronary spasm. Circulation. 1993, 87:76-9. 10.1161\/01.cir.87.1.76","journal-title":"Circulation"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.07.018","article-title":"Prognostic stratification of patients with vasospastic angina: a comprehensive clinical risk score developed by the Japanese Coronary Spasm Association","volume":"62","author":"Takagi Y","year":"2013","unstructured":"Takagi Y, Takahashi J, Yasuda S, et al.. Prognostic stratification of patients with vasospastic angina: a comprehensive clinical risk score developed by the Japanese Coronary Spasm Association. J Am Coll Cardiol. 2013, 62:1144-53. 10.1016\/j.jacc.2013.07.018","journal-title":"J Am Coll Cardiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.4330\/wjc.v10.i11.201","article-title":"Coronary spasm: it's common, but it's still unsolved","volume":"10","author":"Teragawa H","year":"2018","unstructured":"Teragawa H, Oshita C, Ueda T. Coronary spasm: it's common, but it's still unsolved. World J Cardiol. 2018, 10:201-9. 10.4330\/wjc.v10.i11.201","journal-title":"World J Cardiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.4330\/wjc.v10.i3.15","article-title":"Increased frequency of angina attacks caused by switching a brand-name vasodilator to a generic vasodilator in patients with vasospastic angina: two case reports","volume":"10","author":"Goto-Semba R","year":"2018","unstructured":"Goto-Semba R, Fujii Y, Ueda T, Oshita C, Teragawa H. Increased frequency of angina attacks caused by switching a brand-name vasodilator to a generic vasodilator in patients with vasospastic angina: two case reports. World J Cardiol. 2018, 10:15-20. 10.4330\/wjc.v10.i3.15","journal-title":"World J Cardiol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jjcc.2021.12.011","article-title":"Kampo medicine for the holistic approach to older adults with heart failure","volume":"80","author":"Yaku H","year":"2022","unstructured":"Yaku H, Kaneda K, Kitamura J, Kato T, Kimura T. Kampo medicine for the holistic approach to older adults with heart failure. J Cardiol. 2022, 80:306-12. 10.1016\/j.jjcc.2021.12.011","journal-title":"J Cardiol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2016.00219","article-title":"Kampo medicine: evaluation of the pharmacological activity of 121 herbal drugs on GABAA and 5-HT3A receptors","volume":"7","author":"Hoffmann KM","year":"2016","unstructured":"Hoffmann KM, Herbrechter R, Ziemba PM, et al.. Kampo medicine: evaluation of the pharmacological activity of 121 herbal drugs on GABAA and 5-HT3A receptors. Front Pharmacol. 2016, 7:219. 10.3389\/fphar.2016.00219","journal-title":"Front Pharmacol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1142\/S0192415X12500668","article-title":"Traditional Japanese herbal (kampo) medicines and treatment of ocular diseases: a review","volume":"40","author":"Hayasaka S","year":"2012","unstructured":"Hayasaka S, Kodama T, Ohira A. Traditional Japanese herbal (kampo) medicines and treatment of ocular diseases: a review. Am J Chin Med. 2012, 40:887-904. 10.1142\/S0192415X12500668","journal-title":"Am J Chin Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2015.00176","article-title":"Traditional Japanese herbal medicines for treatment of odontopathy","volume":"6","author":"Yamaguchi K","year":"2015","unstructured":"Yamaguchi K. Traditional Japanese herbal medicines for treatment of odontopathy. Front Pharmacol. 2015, 6:176. 10.3389\/fphar.2015.00176","journal-title":"Front Pharmacol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3390\/medicines5040130","article-title":"Kampo (traditional Japanese herbal) formulae for treatment of stomatitis and oral mucositis","volume":"5","author":"Sunagawa M","year":"2018","unstructured":"Sunagawa M, Yamaguchi K, Tsukada M, Ebihara N, Ikemoto H, Hisamitsu T. Kampo (traditional Japanese herbal) formulae for treatment of stomatitis and oral mucositis. Medicines (Basel). 2018, 5:130. 10.3390\/medicines5040130","journal-title":"Medicines (Basel)"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1002\/ijgo.12781","article-title":"Safety and effectiveness of Japanese herbal Kampo medicines for treatment of hyperemesis gravidarum","volume":"145","author":"Michihata N","year":"2019","unstructured":"Michihata N, Shigemi D, Sasabuchi Y, Matsui H, Jo T, Yasunaga H. Safety and effectiveness of Japanese herbal Kampo medicines for treatment of hyperemesis gravidarum. Int J Gynaecol Obstet. 2019, 145:182-6. 10.1002\/ijgo.12781","journal-title":"Int J Gynaecol Obstet"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2020.00086","article-title":"Kampo medicine for various aging-related symptoms: a review of geriatric syndrome","volume":"7","author":"Takayama S","year":"2020","unstructured":"Takayama S, Tomita N, Arita R, Ono R, Kikuchi A, Ishii T. Kampo medicine for various aging-related symptoms: a review of geriatric syndrome. Front Nutr. 2020, 7:86. 10.3389\/fnut.2020.00086","journal-title":"Front Nutr"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jjcc.2019.05.003","article-title":"Effects of Mokuboito, a Japanese Kampo medicine, on symptoms in patients hospitalized for acute decompensated heart failure - a prospective randomized pilot study","volume":"74","author":"Ezaki H","year":"2019","unstructured":"Ezaki H, Ayaori M, Sato H, Maeno Y, Taniwaki M, Miyake T, Sakurada M. Effects of Mokuboito, a Japanese Kampo medicine, on symptoms in patients hospitalized for acute decompensated heart failure - a prospective randomized pilot study. J Cardiol. 2019, 74:412-7. 10.1016\/j.jjcc.2019.05.003","journal-title":"J Cardiol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2023.02.013","article-title":"Rationale and study design of the GOREISAN for heart failure (GOREISAN-HF) trial: a randomized clinical trial","volume":"260","author":"Yaku H","year":"2023","unstructured":"Yaku H, Kato T, Morimoto T, et al.. Rationale and study design of the GOREISAN for heart failure (GOREISAN-HF) trial: a randomized clinical trial. Am Heart J. 2023, 260:18-25. 10.1016\/j.ahj.2023.02.013","journal-title":"Am Heart J"},{"key":"ref29","article-title":"A case of coronary spastic angina treated with Mokuboito, which could reduce the frequency of sublingual nitroglycerin (in Japanese)","volume":"25","author":"Fukushima T","year":"2001","unstructured":"Fukushima T, Makita T, Yamamoto M, et al.. A case of coronary spastic angina treated with Mokuboito, which could reduce the frequency of sublingual nitroglycerin (in Japanese). Sci Kampo Med. 2001, 25:215.","journal-title":"Sci Kampo Med"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3937\/kampomed.54.945","article-title":"A case of microvascular angina treated with Dai-Kankyo-to","volume":"54","author":"Kimura H","year":"2003","unstructured":"Kimura H, Kouta K, Mitsuma T. A case of microvascular angina treated with Dai-Kankyo-to. Kampo Med. 2003, 54:945-50. 10.3937\/kampomed.54.945","journal-title":"Kampo Med"},{"key":"ref31","article-title":"From the medical records of Kitasato University Oriental Medicine Research Center (37)-a case of coronary spastic angina treated with Karogaihakuhangeto (in Japanese)","volume":"53","author":"Suzuki K","year":"2006","unstructured":"Suzuki K, Ito T, Muranushi A, et al.. From the medical records of Kitasato University Oriental Medicine Research Center (37)-a case of coronary spastic angina treated with Karogaihakuhangeto (in Japanese). J Kampo Med. 2006, 53:1890-5.","journal-title":"J Kampo Med"},{"key":"ref32","article-title":"A case of variant angina with excellent response to Keishibukuryogan (Article in Japanese)","volume":"40","author":"Naito M","year":"2006","unstructured":"Naito M, Watanabe S. A case of variant angina with excellent response to Keishibukuryogan (Article in Japanese). Tiryo-gaku. 2006, 40:96-9.","journal-title":"Tiryo-gaku"},{"key":"ref33","article-title":"A case of microvascular angina pectoris refractory to western drugs that could be managed with Toukitou (Article in Japanese)","volume":"56","author":"Namiki T","year":"2009","unstructured":"Namiki T, Kasahara Y, Ohno K, et al.. A case of microvascular angina pectoris refractory to western drugs that could be managed with Toukitou (Article in Japanese). J Kampo Med. 2009, 56:2071-6.","journal-title":"J Kampo Med"},{"key":"ref34","article-title":"Three cases of coronary spastic angina succesfully treated with saibokuto","volume":"57","author":"Shudo T","year":"2010","unstructured":"Shudo T, Kageyama M, Nishida S. Three cases of coronary spastic angina succesfully treated with saibokuto. J Kampo Med. 2010, 57:21-30.","journal-title":"J Kampo Med"},{"key":"ref35","article-title":"A 45y.o. case report of coronary spastic angina who cannot take vasodilators because of severe headache side-effect was successfully treated with saibokuto (in Japanese title)","volume":"463","author":"Shudo T","year":"2010","unstructured":"Shudo T, Kageyama M, Nishida S. A 45y.o. case report of coronary spastic angina who cannot take vasodilators because of severe headache side-effect was successfully treated with saibokuto (in Japanese title). Progr Kampo Med. 2010, 463:259-61.","journal-title":"Progr Kampo Med"},{"key":"ref36","article-title":"A case report of vasospastic angina in which chest oppression attacks were successfully treated with the collaboration of vasodilators and saibokuto (Chai-Po-Tang, Combined Minor Buplerum, Decoction and Pinellia and Magnolia Bark Decoction)","volume":"21","author":"Shudo T","year":"2011","unstructured":"Shudo T, Kageyama M, Aoki M, et al.. A case report of vasospastic angina in which chest oppression attacks were successfully treated with the collaboration of vasodilators and saibokuto (Chai-Po-Tang, Combined Minor Buplerum, Decoction and Pinellia and Magnolia Bark Decoction). Pain Kampo Med. 2011, 21:76-9.","journal-title":"Pain Kampo Med"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.3937\/kampomed.65.287","article-title":"Two cases of vasospastic angina poorly controlled with western medicine successfully treated with a combination of traditional Shigyakusan and Keishibukuryogan Japanese herbals","volume":"65","author":"Yamazaki T","year":"2014","unstructured":"Yamazaki T, Mine T, Hijikata Y. Two cases of vasospastic angina poorly controlled with western medicine successfully treated with a combination of traditional Shigyakusan and Keishibukuryogan Japanese herbals. Kampo Med. 2014, 65:287-92. 10.3937\/kampomed.65.287","journal-title":"Kampo Med"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.7793\/jcad.27.21-00012","article-title":"Potential treatments for refractory vasospastic ngina","volume":"27","author":"Ito S","year":"2021","unstructured":"Ito S, Shimizu Y. Potential treatments for refractory vasospastic ngina. J Coronary Artery Dis. 2021, 27:72-82. 10.7793\/jcad.27.21-00012","journal-title":"J Coronary Artery Dis"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-22-0779","article-title":"JCS\/CVIT\/JCC 2023 guideline focused update on diagnosis and treatment of vasospastic angina (coronary spastic angina) and coronary microvascular dysfunction [PREPRINT]","author":"Hokimoto S","year":"2023","unstructured":"Hokimoto S, Kaikita K, Yasuda S, et al.. JCS\/CVIT\/JCC 2023 guideline focused update on diagnosis and treatment of vasospastic angina (coronary spastic angina) and coronary microvascular dysfunction [PREPRINT]. Circ J. 2023, 10.1253\/circj.CJ-22-0779","journal-title":"Circ J"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.3937\/kampomed.47.617","article-title":"The effects of Tokishakuyaku-San and mokuboi-to on coronary spasm in swine","volume":"47","author":"Yamada T","year":"1997","unstructured":"Yamada T, Oinuma T, Yoshimura M, et al.. The effects of Tokishakuyaku-San and mokuboi-to on coronary spasm in swine. Kampo Med. 1997, 47:617-24. 10.3937\/kampomed.47.617","journal-title":"Kampo Med"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1097\/PSY.0000000000000666","article-title":"Coronary artery spasm as related to anxiety and depression: a nationwide population-based study","volume":"81","author":"Hung MY","year":"2019","unstructured":"Hung MY, Mao CT, Hung MJ, et al.. Coronary artery spasm as related to anxiety and depression: a nationwide population-based study. Psychosom Med. 2019, 81:237-45. 10.1097\/PSY.0000000000000666","journal-title":"Psychosom Med"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.757","article-title":"Inhibitory effects of Keishi-bukuryo-gan on free radical induced lysis of rat red blood cells","volume":"16","author":"Sekiya N","year":"2002","unstructured":"Sekiya N, Goto H, Shimada Y, Terasawa K. Inhibitory effects of Keishi-bukuryo-gan on free radical induced lysis of rat red blood cells. Phytother Res. 2002, 16:373-6. 10.1002\/ptr.757","journal-title":"Phytother Res"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.945","article-title":"Keishi-bukuryo-gan preserves the endothelium dependent relaxation of thoracic aorta in cholesterol-fed rabbit by limiting superoxide generation","volume":"16","author":"Sekiya N","year":"2002","unstructured":"Sekiya N, Goto H, Tazawa K, Oida S, Shimada Y, Terasawa K. Keishi-bukuryo-gan preserves the endothelium dependent relaxation of thoracic aorta in cholesterol-fed rabbit by limiting superoxide generation. Phytother Res. 2002, 16:524-8. 10.1002\/ptr.945","journal-title":"Phytother Res"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.30.1042","article-title":"Effects of keishibukuryogan on vascular function in adjuvant-induced arthritis rats","volume":"30","author":"Nozaki K","year":"2007","unstructured":"Nozaki K, Goto H, Nakagawa T, Hikiami H, Koizumi K, Shibahara N, Shimada Y. Effects of keishibukuryogan on vascular function in adjuvant-induced arthritis rats. Biol Pharm Bull. 2007, 30:1042-7. 10.1248\/bpb.30.1042","journal-title":"Biol Pharm Bull"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2007.11.019","article-title":"Keishibukuryogan ameliorates glucose intolerance and hyperlipidemia in Otsuka Long-Evans Tokushima Fatty (OLETF) rats","volume":"80","author":"Nakagawa T","year":"2008","unstructured":"Nakagawa T, Goto H, Hussein G, Hikiami H, Shibahara N, Shimada Y. Keishibukuryogan ameliorates glucose intolerance and hyperlipidemia in Otsuka Long-Evans Tokushima Fatty (OLETF) rats. Diabetes Res Clin Pract. 2008, 80:40-7. 10.1016\/j.diabres.2007.11.019","journal-title":"Diabetes Res Clin Pract"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgo.2011.03.006","article-title":"Effects of the Kampo medication keishibukuryogan on blood pressure in perimenopausal and postmenopausal women","volume":"114","author":"Terauchi M","year":"2011","unstructured":"Terauchi M, Akiyoshi M, Owa Y, Kato K, Obayashi S, Kubota T. Effects of the Kampo medication keishibukuryogan on blood pressure in perimenopausal and postmenopausal women. Int J Gynaecol Obstet. 2011, 114:149-52. 10.1016\/j.ijgo.2011.03.006","journal-title":"Int J Gynaecol Obstet"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2021.760918","article-title":"A review on the mechanism and application of Keishibukuryogan","volume":"8","author":"Tanaka K","year":"2021","unstructured":"Tanaka K, Chiba K, Nara K. A review on the mechanism and application of Keishibukuryogan. Front Nutr. 2021, 8:760918. 10.3389\/fnut.2021.760918","journal-title":"Front Nutr"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1097\/00019501-199305000-00007","article-title":"Platelet-derived growth factor is released into the coronary circulation after coronary spasm","volume":"4","author":"Ogawa H","year":"1993","unstructured":"Ogawa H, Yasue H, Okumura K, et al.. Platelet-derived growth factor is released into the coronary circulation after coronary spasm. Coron Artery Dis. 1993, 4:437-42. 10.1097\/00019501-199305000-00007","journal-title":"Coron Artery Dis"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.6292-20","article-title":"Adverse effects of Kampo medicines","volume":"61","author":"Shimada Y","year":"2022","unstructured":"Shimada Y. Adverse effects of Kampo medicines. Intern Med. 2022, 61:29-35. 10.2169\/internalmedicine.6292-20","journal-title":"Intern Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/142571-japanese-herbal-medicine-kampo-as-a-possible-treatment-for-ischemia-with-non-obstructive-coronary-artery-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:56:17Z","timestamp":1707508577000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/142571-japanese-herbal-medicine-kampo-as-a-possible-treatment-for-ischemia-with-non-obstructive-coronary-artery-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,28]]},"references-count":49,"URL":"https:\/\/doi.org\/10.7759\/cureus.38239","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,28]]}}}